DRKS00012890暂停不适用
Analysis of tumor DNA markers in the plasma of colorectal cancer patients by liquid biopsy - Liquid Biopsy in colorectal cancer patients
Medizinisch Genetisches Zentrum (MGZ)0 个研究点目标入组 100 人开始时间: 2017年9月14日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 暂停
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Microsatellite stable colorectal cancer
排除标准
- •Neoadjuvant radio or chemotherapy has already started
研究者
相似试验
已完成
不适用
A biomarker analysis of plasma and tumor DNA in afatinib-treatedpatients with EGFR mutation-positive advanced adenocarcinoma of the lung.adenocarcinoma of the lungJPRN-UMIN000013806Clinical Research Support Center Kyushu30
尚未招募
不适用
Cancer gene panel of plasma DNA in patients with solid tumorJPRN-UMIN000040506Shizuoka Cancer Center30
招募中
不适用
Observational Study of circulating-tumor DNA in Patients with Gastrointestinal CancerEsophageal cancer, Esophago-gastric junctional cancer, Gastric cancerJPRN-UMIN000042003ational Cancer Center Hospital East200
招募中
不适用
Circulating tumor DNA as a noninvasive biomarker in patients with thyroid cancerC73Malignant neoplasm of thyroid glandDRKS00022441niversitätsklinikum Freiburg75
招募中
不适用
Circulating tumor DNA as a noninvasive biomarker in patients with Non-Hodgkin Lymphoma (NHL)C83.3C85Diffuse large B-cell lymphomaOther and unspecified types of non-Hodgkin lymphomaDRKS00024180niversitätsklinikum Freiburg200